What are your thoughts on This Artical..
Bioshares recommendation: Speculative Hold Class B Timing -
Company Biotron Code BIT CMP $0.088 Cap'n ($M) $20.1 Cash ($M) 30/9 $3.5 SI 1.0
• Biotron is developing BIT225 to treat HCV and HIV co-infection; it has a novel mechanism of action, targeting the p7 protein on the virus
• Phase IIa trial showed that BIT225 twice daily in combo with ribavarin and peg-interferon reduced virus to undetectable levels after 28 days
• BIT's rationale for developing BIT225 is that it can address drug resistance issues that could emerge with other classes of HCV drugs
• Recently Gilead Sciences' sofusbuvir with ribavirin was recommended for approval by the FDA, for treating HCV genotypes 2 and 3
• Sofusbuvir with pegylated interferon was also recommended for approval for treating HCV genotypes 1 and 4
• Sofusbuvir cuts duration of treatment from 24 to 12 weeks, and delivers up to a 90% cure rate
• Gilead has a pan-genotype and interferon and ribavarin free regime of sofusbuvir and GS-5816 moving into Phase II
• Johnson & Johnson's simeprevir with peg-interferon and ribavarin for genotype 1, was also recommended for approval
• BIT intends to commence a 12 week trial of BIT225 in genotypes 1 and 3 subjects later in 2013
Comment: The number of new and improved HCV drugs nearing FDA approval diminish the prospects for BIT225
Bioshares recommendation: Sell Timing
- Forums
- ASX - By Stock
- BIT
- artical in bio shares
artical in bio shares
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $41.50M |
Open | High | Low | Value | Volume |
4.4¢ | 4.7¢ | 4.4¢ | $31.64K | 708.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 17361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 0.045 |
1 | 200000 | 0.044 |
4 | 438255 | 0.043 |
4 | 342000 | 0.042 |
4 | 287000 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 17361 | 1 |
0.047 | 225000 | 2 |
0.048 | 308915 | 1 |
0.050 | 21000 | 1 |
0.051 | 96225 | 3 |
Last trade - 14.10pm 21/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online